The relationship between genetic profiling, clinicopathological factors and survival in patients undergoing surgery for node-negative colorectal cancer: 10-year follow-up

[1] Al-Mulla F(2006)Genetic profiling of stage I and II colorectal cancer may predict metastatic relapse Mod Pathol 19 648-658

[2] Behbehani AI(1999)Prospective assessment of allelic losses at 4p14-16 in colorectal cancer: two mutational patterns and a locus associated with poorer survival Clin Cancer Res 5 3454-3459

[3] Bitar MS(2010)Adjuvant chemotherapy for resected stage II and III colon cancer: comparison of two widely used prognostic calculators Semin Oncol 37 39-46

[4] Varadharaj G(2007)New approaches to assessing and treating early-stage colon and rectal cancers: cooperative group strategies for assessing optimal approaches in early-stage disease Clin Cancer Res 13 6913s-6920s

[5] Going JJ(2004)American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer J Clin Oncol 22 3408-3419

[6] Arribas R(2009)Genomic Aberrations in Squamous Cell Lung Carcinoma Related to Lymph Node or Distant Metastases Lung Cancer 66 372-378

[7] Ribas M(2005)Inflammation and prognosis in colorectal cancer Eur J Cancer 41 2645-2654

[8] Risques RA(2010)A clinical risk score to predict 3-, 5- and 10-year survival in patients undergoing surgery for Dukes’ A colorectal cancer Br J Cancer 103 970-974

[9] Masramon L(2012)Review of biomarkers in colorectal cancer Colorectal Dis 14 3-17

[10] Tórtola S(2003)Chromosomal instability rather than p53 mutation is associated with response to neoadjuvant cisplatin-based chemotherapy in gastric carcinoma Clin Cancer Res 9 2307-2315

[1] Al-Mulla F(2006)Genetic profiling of stage I and II colorectal cancer may predict metastatic relapse Mod Pathol 19 648-658

[2] Behbehani AI(1999)Prospective assessment of allelic losses at 4p14-16 in colorectal cancer: two mutational patterns and a locus associated with poorer survival Clin Cancer Res 5 3454-3459

[3] Bitar MS(2010)Adjuvant chemotherapy for resected stage II and III colon cancer: comparison of two widely used prognostic calculators Semin Oncol 37 39-46

[4] Varadharaj G(2007)New approaches to assessing and treating early-stage colon and rectal cancers: cooperative group strategies for assessing optimal approaches in early-stage disease Clin Cancer Res 13 6913s-6920s

[5] Going JJ(2004)American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer J Clin Oncol 22 3408-3419

[6] Arribas R(2009)Genomic Aberrations in Squamous Cell Lung Carcinoma Related to Lymph Node or Distant Metastases Lung Cancer 66 372-378

[7] Ribas M(2005)Inflammation and prognosis in colorectal cancer Eur J Cancer 41 2645-2654

[8] Risques RA(2010)A clinical risk score to predict 3-, 5- and 10-year survival in patients undergoing surgery for Dukes’ A colorectal cancer Br J Cancer 103 970-974

[9] Masramon L(2012)Review of biomarkers in colorectal cancer Colorectal Dis 14 3-17

[10] Tórtola S(2003)Chromosomal instability rather than p53 mutation is associated with response to neoadjuvant cisplatin-based chemotherapy in gastric carcinoma Clin Cancer Res 9 2307-2315